06Dec 2022 by Soria Khozami No Comments
What Do You Need To Know About Sertraline?

What Do You Need To Know About Sertraline?

Nervous System
What is Sertraline and what are the indications of it? Sertraline (Zoloft) is antidepressant. It belongs to the class of medicines known as Selective Serotonin Reuptake Inhibitors (SSRIs) with little or no affinity for alpha-adrenergic histamine or cholinergic receptor. The dosage form of it are: tablets, capsules and oral solution. Sertraline is indicated to treat: Major depressive disorder (MDD). Obsessive-compulsive disorder (OCD). Panic Disorder. Posttraumatic stress disorder (PTSD). Social Anxiety Disorder (SAD). Premenstrual dysphoric disorder (PMDD). The dosage of Sertraline depends on age, pharmaceutical form, weight, pathological condition, liver and kidney function. What are the most common side effects of Sertraline and how to reduce them? Nausea: Try to take Sertraline with or after food. Nausea usually improves over time as your body adjusts to the medication. Headache: Make sure…
Read More
27Nov 2022 by Hala Ahmad No Comments
What do you know about Pheochromocytoma?

What do you know about Pheochromocytoma?

Nervous System
Pheochromocytoma (PCC): These are tumors of the adrenal glands, which are located just above the kidneys. Pheochromocytoma causes the adrenal glands to produce too many stress hormones (adrenaline and noradrenaline), resulting in high blood pressure and other symptoms such as severe headache, irritability, sweating, fast heart rate, nausea, vomiting, weight loss, weakness, and chest pain. This type of tumor rarely occurs outside the adrenal gland (in the abdomen) called (an extra-adrenal pheochromocytoma or paraganglioma) The cause: PCC can develop at any age, but it is most common in early to mid-adulthood. • The condition is often thought to be hereditary, as well as the cause of most pheochromocytomas is unknown. But in some cases, there is a genetic cause. • This type of tumor may occur in some familial genetic syndromes kidney…
Read More